Recombinant Uncharacterized Protein Rv0970/MT0998 corresponds to the Rv0970 gene (also annotated as MT0998) in M. tuberculosis, encoding a hypothetical protein of unknown function. Its UniProt ID is P64781. The recombinant version is synthesized using heterologous expression systems, enabling studies on its potential role in tuberculosis pathogenesis or bacterial physiology .
| Property | Detail |
|---|---|
| Organism | Mycobacterium tuberculosis |
| Gene Name | Rv0970, MT0998 |
| UniProt ID | P64781 |
| Protein Length | 210 amino acids |
| Molecular Weight | ~23 kDa (calculated) |
The recombinant protein is typically expressed in E. coli, yeast, or mammalian systems, fused with an N-terminal His-tag for affinity chromatography .
Though functionally uncharacterized, this protein is employed in:
ELISA Development: Used as an antigen for antibody validation .
Protein Interaction Studies: Screened via yeast two-hybrid or pull-down assays .
Structural Biology: Crystallization trials for 3D modeling .
Rigorous quality assessments ensure batch consistency:
The lack of functional annotation limits hypothesis-driven studies. Current research focuses on:
Identifying interactors via proteomic screens.
Mapping its role in M. tuberculosis virulence using knockout models.
The Rv0970/MT0998 gene is located in the Mycobacterium tuberculosis genome and has been identified through genomic sequencing. Like many mycobacterial proteins with Rv/MT designations, this nomenclature indicates its identification in reference strains of M. tuberculosis. The Rv designation refers to the H37Rv reference strain, while MT refers to the CDC1551 clinical isolate. Understanding the genomic context can provide initial insights into potential functional relationships with adjacent genes and possible operon structures .
Based on sequence analysis, Rv0970/MT0998 is predicted to be a hypothetical protein with currently uncharacterized function. Bioinformatic analysis suggests the protein may contain specific domains that could indicate potential functional roles. Common prediction tools like PSIPRED, I-TASSER, and AlphaFold can be used to generate potential structural models. These computational approaches provide a starting point for experimental validation, though they should be interpreted cautiously until confirmed through methods like X-ray crystallography or NMR spectroscopy .
For recombinant production of mycobacterial proteins like Rv0970/MT0998, Escherichia coli expression systems are often the first choice due to their ease of use and high yield. The BL21(DE3) strain is particularly useful for expression of mycobacterial proteins due to its lack of certain proteases. For optimal expression, consider using vectors with inducible promoters such as pET series vectors with T7 promoters. Alternative expression systems include mycobacterial hosts like M. smegmatis, which may provide more native-like post-translational modifications but typically yield lower protein amounts .
Confirmation of purified Rv0970/MT0998 should involve multiple analytical techniques. Western blotting using anti-His antibodies (if a His-tag was incorporated) provides initial verification. Mass spectrometry remains the gold standard, with techniques like MALDI-TOF or LC-MS/MS allowing for precise molecular weight determination and peptide sequencing. A typical confirmation workflow should include:
SDS-PAGE to assess purity and approximate molecular weight
Western blot with appropriate antibodies
Mass spectrometry for definitive identification
Functional characterization of uncharacterized proteins like Rv0970/MT0998 requires multiple complementary approaches. Begin with computational prediction of potential functions based on sequence homology, domain architecture, and structural modeling. Follow with targeted experimental approaches including:
Gene knockout or knockdown studies in M. tuberculosis to assess essentiality
Transcriptomic analysis to identify conditions affecting expression
Proteomic approaches to identify interaction partners
Biochemical assays to test predicted enzymatic activities
Phenotypic screening of mutants under various stress conditions
A systematic combination of these approaches provides the most comprehensive functional characterization, particularly when results from multiple methods converge on consistent functional hypotheses .
Investigation of protein-protein interactions for Rv0970/MT0998 requires both in vitro and in vivo approaches. Begin with pull-down assays using tagged recombinant Rv0970/MT0998 as bait against mycobacterial lysates. Co-immunoprecipitation with antibodies specific to Rv0970/MT0998 can identify native interaction partners. For comprehensive interactome mapping, consider:
Yeast two-hybrid screening against a mycobacterial library
Bacterial two-hybrid systems, which may be more suitable for mycobacterial proteins
Proximity-dependent biotin labeling (BioID) for in vivo interaction mapping
Cross-linking mass spectrometry (XL-MS) to capture transient or weak interactions
Confirmation of identified interactions should involve reciprocal pull-downs and functional validation through co-localization studies or mutational analysis of interaction interfaces .
While specific pathogenic roles for Rv0970/MT0998 remain to be determined, several approaches can help investigate its potential contributions to virulence. Expression analysis during infection models can indicate whether the protein is upregulated during host interaction. Comparative genomics across mycobacterial species can reveal whether the gene is conserved in pathogenic strains but absent in non-pathogenic ones, suggesting virulence functions.
To experimentally assess pathogenic roles:
Generate knockout strains and test for attenuation in cellular and animal infection models
Evaluate the protein's expression during different stages of infection
Assess subcellular localization during host interaction
Investigate potential immunomodulatory effects on host cells
These approaches collectively can provide insights into whether Rv0970/MT0998 contributes to M. tuberculosis pathogenesis and through what mechanisms .
Optimizing expression and purification of Rv0970/MT0998 requires systematic testing of multiple conditions. For E. coli-based expression systems, consider the following parameters:
Expression temperature: 18°C often yields better folding for mycobacterial proteins
Induction concentration: Lower IPTG concentrations (0.1-0.5 mM) typically improve solubility
Growth media: Enriched media like Terrific Broth often increases yield
Co-expression with chaperones: GroEL/GroES can improve folding of mycobacterial proteins
For purification, a typical workflow includes:
Initial capture via affinity chromatography (IMAC for His-tagged proteins)
Intermediate purification via ion exchange chromatography
Polishing step using size exclusion chromatography
The buffer composition should be optimized through stability screening, with typical starting conditions including 50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 5% glycerol to enhance stability .
Designing effective gene knockout experiments for Rv0970/MT0998 requires careful consideration of mycobacterial genetics. For M. tuberculosis, specialized techniques are needed due to low transformation efficiency and slow growth. Consider the following approaches:
Homologous recombination using specialized vectors like pJM1 or pYUB854
Transposon mutagenesis libraries for initial essentiality screening
CRISPR-Cas9 based methods, though these are still being optimized for mycobacteria
Conditional knockdown systems if the gene proves essential
A comprehensive experimental design should include:
Construction of knockout vectors with appropriate selectable markers
Confirmation of gene deletion by PCR and sequencing
Complementation studies to verify phenotypes are specific to gene deletion
Growth curve analysis under various conditions
Stress response testing (oxidative, acid, nutrient limitation)
Virulence assessment in cellular and animal models
Controls should include wild-type strains and complemented mutants to ensure observed phenotypes are directly attributable to Rv0970/MT0998 disruption .
Determining the structure of Rv0970/MT0998 requires selecting appropriate techniques based on protein properties. X-ray crystallography remains the gold standard but requires well-diffracting crystals. NMR spectroscopy is valuable for smaller proteins or dynamic regions. Cryo-electron microscopy (cryo-EM) has emerged as powerful for proteins resistant to crystallization.
A comprehensive structural biology approach would include:
Initial screening with circular dichroism to assess secondary structure content
Crystallization trials with various constructs and conditions
NMR studies for dynamic regions or if the protein is under 25 kDa
Cryo-EM for larger assemblies or membrane-associated forms
Small-angle X-ray scattering (SAXS) for solution-state conformation
Computational predictions using AlphaFold2 can guide experimental design by identifying structured domains and disordered regions that may impact crystallization. Integrating multiple structural techniques provides the most comprehensive structural characterization .
Analyzing expression data for Rv0970/MT0998 across varied conditions requires robust statistical approaches and appropriate normalization. For transcriptomic data (RNA-seq or microarray), consider the following:
Normalize using established methods like RPKM/FPKM or TPM for RNA-seq data
Apply appropriate statistical tests (DESeq2, edgeR) to identify significant changes
Compare expression patterns with co-regulated genes
Integrate with regulatory network information
The following table summarizes example expression data analysis from a hypothetical study of Rv0970/MT0998 under various stress conditions:
| Condition | Log2 Fold Change | p-value | FDR | Co-regulated genes |
|---|---|---|---|---|
| Hypoxia | 2.34 | 0.0012 | 0.008 | Rv0971, Rv0969, Rv0973 |
| Acid stress | 1.87 | 0.0031 | 0.015 | Rv1733c, Rv2031c |
| Nutrient starvation | 3.21 | 0.0005 | 0.003 | Rv0970, Rv3133c |
| Oxidative stress | 0.43 | 0.1243 | 0.312 | None significant |
| Macrophage infection | 2.75 | 0.0008 | 0.006 | Rv0967, Rv0970, Rv1738 |
Clustering analysis of expression patterns can reveal functional relationships with genes of known function, providing clues to Rv0970/MT0998's role in mycobacterial physiology .
Contradictory results are common when characterizing uncharacterized proteins like Rv0970/MT0998. Resolving such discrepancies requires systematic analysis of experimental variables and methodological differences. Consider these approaches:
Evaluate strain differences: Results may vary between lab strains and clinical isolates
Assess experimental conditions: Growth phase, media composition, and stress levels can affect outcomes
Compare methodological details: Different assay sensitivities or detection methods may explain variations
Consider genetic compensation: Adaptive responses may mask phenotypes in some experimental setups
A structured approach to resolving contradictions involves:
Repeating key experiments with standardized protocols
Testing multiple complementary methods to assess the same function
Collaborating with labs reporting different results to identify variables
Considering whether contradictory results actually reveal condition-specific functions
Document all experimental conditions meticulously, including strain details, growth conditions, and exact methodological parameters to facilitate comparison across studies and resolution of apparent contradictions .
Bioinformatic prediction of Rv0970/MT0998 function should employ multiple algorithms and databases to increase confidence. Key approaches include:
Sequence homology using BLAST against well-characterized proteins
Domain identification using InterPro, Pfam, and SMART databases
Structural modeling using AlphaFold2 followed by structural similarity searches
Gene neighborhood analysis to identify functional relationships
Co-evolution analysis to predict interaction partners
The following table summarizes hypothetical results from bioinformatic prediction approaches:
| Method | Prediction | Confidence Score | Supporting Evidence |
|---|---|---|---|
| BLAST homology | Possible oxidoreductase | 65% | Weak homology to known oxidoreductases |
| Domain prediction | NAD(P)-binding domain | 87% | Rossmann fold detected by InterPro |
| Structural modeling | Structural similarity to dehydrogenases | 76% | AlphaFold2 model aligns with known dehydrogenases |
| Gene neighborhood | Co-occurrence with stress response genes | N/A | Conserved gene cluster in pathogenic mycobacteria |
| Evolutionary analysis | Co-evolution with redox proteins | 72% | Significant correlation with thioredoxin system proteins |
Integration of multiple prediction methods provides a consensus hypothesis that can guide targeted experimental validation of Rv0970/MT0998 function .
Comparative analysis of Rv0970/MT0998 with homologs in other mycobacterial species can provide evolutionary insights and functional clues. Sequence conservation patterns often highlight functionally important residues. A comprehensive analysis should include:
Multiple sequence alignment across diverse mycobacterial species
Phylogenetic analysis to understand evolutionary relationships
Conservation mapping onto predicted structural models
Comparison of genomic context across species
The following table presents a hypothetical comparison of Rv0970/MT0998 across selected mycobacterial species:
| Species | Identity (%) | Similarity (%) | Gene Context Preserved | Key Variations |
|---|---|---|---|---|
| M. tuberculosis H37Rv | 100 | 100 | Reference | None |
| M. tuberculosis CDC1551 | 99.8 | 100 | Yes | 1 conservative aa substitution |
| M. bovis | 98.5 | 99.2 | Yes | 3 aa substitutions in C-terminal region |
| M. marinum | 85.3 | 92.1 | Partially | Extended N-terminal region |
| M. smegmatis | 76.8 | 84.5 | No | Insertions in central domain |
| M. leprae | 82.4 | 88.7 | Yes | Truncated C-terminus |
| M. avium | 79.2 | 86.3 | Partially | Variable central domain |
Higher conservation in pathogenic mycobacteria would suggest potential roles in virulence, while conservation across all mycobacteria would indicate more fundamental cellular functions .
Protein-protein interaction networks provide critical context for understanding Rv0970/MT0998 function. Comprehensive interactome analysis can reveal functional modules and biological processes involving this protein. Approaches to network analysis include:
Direct interactome mapping using affinity purification-mass spectrometry
Yeast two-hybrid screening against the mycobacterial proteome
Computational prediction of interactions based on co-expression data
Integration with existing mycobacterial interactome databases
A hypothetical interaction network analysis might reveal patterns like these:
| Interaction Partner | Detection Method | Interaction Strength | Functional Category |
|---|---|---|---|
| Rv0971 | AP-MS, Y2H | Strong | Cell wall biosynthesis |
| Rv3133c (DosR) | Co-IP | Moderate | Hypoxia response |
| Rv2031c (HspX) | SPINE | Weak | Stress response |
| Rv0967 | BioID | Moderate | Lipid metabolism |
| Rv3418c (GroEL) | AP-MS | Weak | Protein folding |
| Rv2623 | Y2H | Moderate | Persistence |
| Rv0973c | Crosslinking-MS | Strong | Unknown function |
Network visualization and pathway enrichment analysis can further reveal functional clusters and potential biological roles based on the characterized interaction partners. This provides a functional context even when the direct function of Rv0970/MT0998 remains unknown .